Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
NCT01615965 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2015-07-28
Summary
The purpose of this study is to set up a model for detecting micrometastases in Lymph nodes of patients with prostate cancer by quantitative polymerase chain reaction and its impact on progression-free survival.
Conditions
Interventions
- OTHER
-
tumor marker detection in lymph nodes
tumor marker detection in lymph nodes by quantitative PCR
Sponsors & Collaborators
-
Technical University of Munich
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
Countries
- Germany
Study Locations
More Related Trials
-
ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes
NCT02840617 ·Status: UNKNOWN ·Phase: PHASE1
-
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
NCT05819606 ·Status: COMPLETED
-
Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness
NCT02545881 ·Status: UNKNOWN
-
A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
NCT01667536 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients
NCT04832958 ·Status: COMPLETED ·Phase: PHASE2
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
Early and Accurate Detection of Prostate Cancer in General Practice
NCT03431753 ·Status: UNKNOWN ·Phase: NA
-
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT05764005 ·Status: COMPLETED ·Phase: NA
-
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
NCT04964271 ·Status: ACTIVE_NOT_RECRUITING
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
NCT04102553 ·Status: COMPLETED ·Phase: PHASE3
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
NCT00314535 ·Status: COMPLETED
-
Prostate Metabolism, Cancer Risk and Gut Microbiota
NCT06116851 ·Status: RECRUITING
-
Identification of Predictive Biomarkers
NCT04324983 ·Status: COMPLETED ·Phase: NA
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED
-
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
NCT06122584 ·Status: RECRUITING ·Phase: PHASE3
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)
NCT01191931 ·Status: COMPLETED
-
Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis
NCT02998619 ·Status: COMPLETED
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Familial Prostate Cancer
NCT00001377 ·Status: COMPLETED
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING